Latest news
AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth - PR NewswirePR Newswire · Tue, 04 Aug 2026 12:30:00 GMTAsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem - PR NewswirePR Newswire · Mon, 27 Jul 2026 07:00:00 GMT